Exact Mass: 480.2029
Exact Mass Matches: 480.2029
Found 500 metabolites which its exact mass value is equals to given mass value 480.2029
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-[(4-Amino-3-methylphenyl)methyl]-5-(2,2-diphenylacetyl)-6,7-dihydro-4H-imidazo[4,5-c]pyridine-6-carboxylic acid
Acevaltrate
Production by Valeriana subspecies Acevaltrate is found in tea, fats and oils, and herbs and spices. Acevaltrate is found in fats and oils. Acevaltrate is produced by Valeriana specie C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1]. Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1].
1-alpha-Acevaltrate
Constituent of Valeriana species 1-alpha-Acevaltrate is found in tea, fats and oils, and herbs and spices. 1-alpha-Acevaltrate is found in fats and oils. 1-alpha-Acevaltrate is a constituent of Valeriana sp.
5alpha-Pregnan-3beta,20alpha-diol disulfate
5alpha-Pregnan-3beta,20alpha-diol disulfate, also known as 5α-pregnan-3β,20α-ylene sulfate, belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20alpha-diol disulfate is an extremely strong acidic compound (based on its pKa). 5alpha-Pregnan-3beta,20alpha-diol disulfate can be found in feces. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
5alpha-Pregnan-3beta,20beta-diol disulfate
5alpha-Pregnan-3beta,20beta-diol disulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3beta,20beta-diol disulfate has been identified in the human placenta (PMID: 32033212).
5alpha-Pregnan-3alpha,20beta-diol disulfate
5alpha-Pregnan-3alpha,20beta-diol disulfate belongs to the class of organic compounds known as sulfated steroids. These are sterol lipids containing a sulfate group attached to the steroid skeleton. 5alpha-Pregnan-3alpha,20beta-diol disulfate is possibly neutral. 5alpha-Pregnan-3alpha,20beta-diol disulfate has been identified in the human placenta (PMID: 32033212).
(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine
(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is an acylcarnitine. More specifically, it is an (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].
[10,13-Dimethyl-17-(1-sulfooxyethyl)-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] hydrogen sulfate
beclomethasone propionate
Tucatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EH - Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
6,10,11-trihydroxy-8-(3-hydroxy-3-methylbutyl)-3,3-dimethyl-9-(3-methylbut-2-en-1-yl)-3H,7H-pyrano[2,3-c]xanthen-7-one
8beta-hydroxy-teucrolivin B|8??-Hydroxy-teucrolivin B
(6aR)-3-(4-hydroxy-2-methyl-6-oxocyclohexenyl)-6a-methyl-9-(2-methyloctanoyl)-6aH-furo[2,3-h]isochromene-6,8-dione|cohaerin D
2,7,8-Trimethyl-3,6-dimethoxy-[1,3-methylenebis(9H-carbazole)]-4,5-diol
3,4-dihydro-3,6,7,11-tetrahydroxy-8,9-di(3-methyl-2-butenyl)-2,2-dimethyl-pyrano[2,3-c]xanthone
3,3,4,5-tetramethoxybibenzyl-4-O-beta-D-glucopyranoside
1,7-bis-(3,4-dihydoxyphenyl)-5-hydroxy-heptane-3-O-beta-D-xylopyranoside
1,3,7,8-tetrahydroxy-4,6,9-tris(3-methyl-2-buten-1-yl)-11H-dibenzo[b,e][1,4]dioxepin-11-one|oliveridepsidone A
1(O)-acetyl-8alpha-acetoxy-10beta-hydroxy-hirsutinolide 1(O)-isovalerate
(1R*,4R*,5R*,6R*,8S*,10R*)-1,4-Dihydroxy-5,13-diacetoxy-8-tiglyloxycadin-7(11)-en-6,12-olide
Phe Asp Ala Glu
Acevaltrate
Acevaltrate is a fatty acid ester. Acevaltratum is a natural product found in Fedia cornucopiae, Plectritis macrocera, and other organisms with data available. C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1]. Acevaltrate inhibits the Na+/K+-ATPase activity in the rat kidney and brain hemispheres with IC50s of 22.8 μM and 42.3 μM, respectively[1].
[3-(13-methyltetradecyl)-5-sulfooxyphenyl] hydrogen sulfate
Ala Asp Glu Phe
Ala Asp Phe Glu
Ala Glu Asp Phe
Ala Glu Phe Asp
Ala Phe Asp Glu
Ala Phe Glu Asp
Ala Met Pro Tyr
Ala Met Tyr Pro
Ala Asn Asn Tyr
Ala Asn Tyr Asn
Ala Pro Met Tyr
Ala Pro Tyr Met
Ala Tyr Met Pro
Ala Tyr Asn Asn
Ala Tyr Pro Met
Cys Cys Lys Lys
Cys Lys Cys Lys
Cys Lys Lys Cys
Cys Pro Val Tyr
Cys Pro Tyr Val
Cys Val Pro Tyr
Cys Val Tyr Pro
Cys Tyr Pro Val
Cys Tyr Val Pro
Asp Ala Glu Phe
Asp Ala Phe Glu
Asp Glu Ala Phe
Asp Glu Phe Ala
Asp Phe Ala Glu
Asp Phe Glu Ala
Asp Pro Ser Tyr
Asp Pro Tyr Ser
Asp Ser Pro Tyr
Asp Ser Tyr Pro
Asp Tyr Pro Ser
Asp Tyr Ser Pro
Glu Ala Asp Phe
Glu Ala Phe Asp
Glu Asp Ala Phe
Glu Asp Phe Ala
Glu Glu Phe Gly
Glu Glu Gly Phe
Glu Phe Ala Asp
Glu Phe Asp Ala
Glu Phe Glu Gly
Glu Phe Gly Glu
Glu Gly Glu Phe
Glu Gly Phe Glu
Glu Met Thr Thr
Glu Thr Met Thr
Glu Thr Thr Met
Phe Ala Asp Glu
Phe Ala Glu Asp
Phe Asp Glu Ala
Phe Glu Ala Asp
Phe Glu Asp Ala
Phe Glu Glu Gly
Phe Glu Gly Glu
Phe Gly Glu Glu
Phe Met Pro Ser
Phe Met Ser Pro
Phe Asn Asn Ser
Phe Asn Ser Asn
Phe Pro Met Ser
Phe Pro Ser Met
Phe Ser Met Pro
Phe Ser Asn Asn
Phe Ser Pro Met
Phe Val Glu Ser
Phe Val Ser Glu
Phe Val Thr Asp
Gly Glu Glu Phe
Gly Glu Phe Glu
Gly Glu Ile Tyr
Gly Glu Leu Tyr
Gly Glu Tyr Ile
Gly Glu Tyr Leu
Gly Phe Glu Glu
Gly His His Met
Gly His Met His
Gly Ile Glu Tyr
Gly Ile Tyr Glu
Gly Leu Glu Tyr
Gly Leu Tyr Glu
Gly Met His His
Gly Asn Gln Tyr
Gly Asn Tyr Gln
Gly Gln Asn Tyr
Gly Gln Tyr Asn
Gly Tyr Glu Ile
Gly Tyr Glu Leu
Gly Tyr Ile Glu
Gly Tyr Leu Glu
Gly Tyr Asn Gln
Gly Tyr Gln Asn
His Gly His Met
His Gly Met His
His His Gly Met
His His Met Gly
His His Ser Thr
His His Thr Ser
His Met Gly His
His Met His Gly
His Met Pro Pro
His Asn Asn Pro
His Asn Pro Asn
His Pro Met Pro
His Pro Asn Asn
His Pro Pro Met
His Ser His Thr
His Ser Thr His
His Thr His Ser
His Thr Ser His
Ile Ala Asp Tyr
Ile Ala Tyr Asp
Ile Asp Ala Tyr
Ile Asp Phe Ser
Ile Met Met Ser
Ile Met Ser Met
Ile Ser Met Met
Lys Cys Cys Lys
Lys Cys Lys Cys
Lys Lys Cys Cys
Leu Met Met Ser
Leu Met Ser Met
Leu Ser Met Met
Met Ala Pro Tyr
Met Ala Tyr Pro
Met Glu Thr Thr
Met Phe Pro Ser
Met Phe Ser Pro
Met Gly His His
Met His Gly His
Met His His Gly
Met His Pro Pro
Met Ile Met Ser
Met Ile Ser Met
Met Leu Met Ser
Met Leu Ser Met
Met Met Ile Ser
Met Met Leu Ser
Met Met Ser Ile
Met Met Ser Leu
Met Met Thr Val
Met Met Val Thr
Met Pro Ala Tyr
Met Pro Phe Ser
Met Pro His Pro
Met Pro Pro His
Met Pro Ser Phe
Met Pro Tyr Ala
Met Ser Phe Pro
Met Ser Ile Met
Met Ser Leu Met
Met Ser Met Ile
Met Ser Met Leu
Met Ser Pro Phe
Met Thr Glu Thr
Met Thr Met Val
Met Thr Thr Glu
Met Thr Val Met
Met Val Met Thr
Met Val Thr Met
Met Tyr Ala Pro
Met Tyr Pro Ala
Asn Ala Asn Tyr
Asn Ala Tyr Asn
Asn Phe Asn Ser
Asn Phe Ser Asn
Asn Gly Gln Tyr
Asn Gly Tyr Gln
Asn His Asn Pro
Asn His Pro Asn
Asn Asn Ala Tyr
Asn Asn Phe Ser
Asn Asn His Pro
Asn Asn Pro His
Asn Asn Ser Phe
Asn Asn Tyr Ala
Asn Pro His Asn
Asn Pro Asn His
Asn Gln Gly Tyr
Asn Gln Tyr Gly
Asn Ser Phe Asn
Asn Ser Asn Phe
Asn Tyr Ala Asn
Asn Tyr Gly Gln
Asn Tyr Asn Ala
Asn Tyr Gln Gly
Pro Ala Met Tyr
Pro Ala Tyr Met
Pro Cys Val Tyr
Pro Cys Tyr Val
Pro Asp Ser Tyr
Pro Asp Tyr Ser
Pro Phe Met Ser
Pro Phe Ser Met
Pro His Met Pro
Pro His Asn Asn
Pro His Pro Met
Pro Met Ala Tyr
Pro Met Phe Ser
Pro Met His Pro
Pro Met Pro His
Pro Met Ser Phe
Pro Met Tyr Ala
Pro Asn His Asn
Pro Asn Asn His
Pro Pro His Met
Pro Pro Met His
Pro Ser Asp Tyr
Pro Ser Phe Met
Pro Ser Met Phe
Pro Ser Tyr Asp
Pro Val Cys Tyr
Pro Val Tyr Cys
Pro Tyr Ala Met
Pro Tyr Cys Val
Pro Tyr Asp Ser
Pro Tyr Met Ala
Pro Tyr Ser Asp
Pro Tyr Val Cys
Gln Gly Asn Tyr
Gln Gly Tyr Asn
Gln Asn Gly Tyr
Gln Asn Tyr Gly
Gln Tyr Gly Asn
Gln Tyr Asn Gly
Ser Asp Pro Tyr
Ser Asp Tyr Pro
Ser Phe Met Pro
Ser Phe Asn Asn
Ser Phe Pro Met
Ser His His Thr
Ser His Thr His
Ser Ile Met Met
Ser Leu Met Met
Ser Met Phe Pro
Ser Met Ile Met
Ser Met Leu Met
Ser Met Met Ile
Ser Met Met Leu
Ser Met Pro Phe
Ser Asn Phe Asn
Ser Asn Asn Phe
Ser Pro Asp Tyr
Ser Pro Phe Met
Ser Pro Met Phe
Ser Pro Tyr Asp
Ser Thr His His
Ser Tyr Asp Pro
Ser Tyr Pro Asp
Thr Glu Met Thr
Thr Glu Thr Met
Thr His His Ser
Thr His Ser His
Thr Met Glu Thr
Thr Met Met Val
Thr Met Thr Glu
Thr Met Val Met
Thr Ser His His
Thr Thr Glu Met
Thr Thr Met Glu
Thr Val Met Met
Val Cys Pro Tyr
Val Cys Tyr Pro
Val Met Met Thr
Val Met Thr Met
Val Pro Cys Tyr
Val Pro Tyr Cys
Val Thr Met Met
Val Tyr Cys Pro
Val Tyr Pro Cys
Tyr Ala Met Pro
Tyr Ala Asn Asn
Tyr Ala Pro Met
Tyr Cys Pro Val
Tyr Cys Val Pro
Tyr Asp Pro Ser
Tyr Asp Ser Pro
Tyr Gly Asn Gln
Tyr Gly Gln Asn
Tyr Met Ala Pro
Tyr Met Pro Ala
Tyr Asn Ala Asn
Tyr Asn Gly Gln
Tyr Asn Asn Ala
Tyr Asn Gln Gly
Tyr Pro Ala Met
Tyr Pro Cys Val
Tyr Pro Asp Ser
Tyr Pro Met Ala
Tyr Pro Ser Asp
Tyr Pro Val Cys
Tyr Gln Gly Asn
Tyr Gln Asn Gly
Tyr Ser Asp Pro
Tyr Ser Pro Asp
Tyr Val Cys Pro
Tyr Val Pro Cys
1-a-Acevaltrate
2-[4-(2,2-dicyanovinyl)-N-ethyl-3-methylanilino]-1-(phenoxymethyl)ethyl carbanilate
DIMETHYL 2-(3-FORMYL-4-((2-METHOXYETHOXY)METHOXY)-5-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)SUCCINATE
[1,1-Biphenyl]-4-carboxylic acid (3aR,4R,5R,6aS)-hexahydro-2-oxo-4-[(1E)-3-oxo-5-phenyl-1-pentenyl]-2H-cyclopenta[b]furan-5-yl ester
Sulfatinib
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor > C93259 - VEGFR Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163953 - VEGFR-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
1,2,3-Propanetricarboxylic acid, 2-[(trimethylsilyl)oxy]-, tris(trimethylsilyl) ester
Tucatinib
L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01E - Protein kinase inhibitors > L01EH - Human epidermal growth factor receptor 2 (her2) tyrosine kinase inhibitors C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C163760 - HER2-targeting Agent C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C159156 - HER2 Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors D000970 - Antineoplastic Agents
[3-(4-{[3,3-Bis(hydroxymethyl)azetidin-1-yl]methyl}phenoxy)azetidin-1-yl][5-(4-methoxyphenyl)-1,3,4-oxadiazol-2-yl]methanone
[9-Chloro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-1-yl] propanoate
(2S)-2-Amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-[(hydroxymethyl)sulfanyl]ethyl]carbamoyl}butanoylcarnitine
N,N,N-tris(3-pyridylmethyl)benzene-1,3,5-tricarboxamide
N-butyl-2-[[6-(4-morpholinyl)-4-oxo-3-(2-phenylethyl)-2-quinazolinyl]thio]acetamide
N,N,N-tris(4-pyridylmethyl)benzene-1,3,5-tricarboxamide
N-[2-(cyclopentylamino)-1-(3,4-dimethoxyphenyl)-2-oxoethyl]-N-[(4-fluorophenyl)methyl]-1H-pyrazole-5-carboxamide
2-(N-[2-(1-benzotriazolyl)-1-oxoethyl]-4-methylanilino)-N-(2-furanylmethyl)-2-(3-pyridinyl)acetamide
(2R,4S)-2-[2-[[(5R)-5-amino-5-carboxypentyl]amino]-2-oxo-1-[(2-phenylacetyl)amino]ethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid
N-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
2-fluoro-N-[(2R,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2R,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2S,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
N-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-1,2-oxazole-4-sulfonamide
2-fluoro-N-[(2S,3R)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
N-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(1R,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1S,3R,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
2-fluoro-N-[(2R,3R)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
N-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]-3,5-dimethyl-4-isoxazolesulfonamide
N-[(1S,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aR,9aS)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3R,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
N-[(1R,3S,4aS,9aR)-3-[2-(cyclopropylmethylamino)-2-oxoethyl]-1-(hydroxymethyl)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-1,3-benzodioxole-5-carboxamide
2-fluoro-N-[(2S,3R)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2R,3S)-4-[[(2R)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
2-fluoro-N-[(2S,3S)-4-[[(2S)-1-hydroxypropan-2-yl]-(4-methylphenyl)sulfonylamino]-2-methoxy-3-methylbutyl]-N-methylbenzamide
(20R)-5alpha-pregnane-3,20-diyl bis(hydrogen sulfate)
(2S,3R,4S)-3-ethenyl-4-[(E)-2-[1-(2-hydroxyethyl)pyridin-1-ium-3-yl]ethenyl]-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-5-carboxylic acid
PD 123177
Pregnane-3,20-diol 3,20-disulfate
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones
9-[2,4-dihydroxy-6-methyl-3-(3-methylbut-2-en-1-yl)benzoyloxy]-1,4-dimethyl-11-methylidene-10-oxotricyclo[6.3.0.0²,⁶]undec-8-ene-4-carboxylic acid
(3r)-3,5,9-trihydroxy-2,2-dimethyl-11,11-bis(3-methylbut-2-en-1-yl)-3,4-dihydro-1,7-dioxatetraphene-10,12-dione
(1r,6r,7r,7as)-4-[(acetyloxy)methyl]-1-[(3-methylbutanoyl)oxy]-6,7a-dihydro-1h-spiro[cyclopenta[c]pyran-7,2'-oxiran]-6-yl 3-(acetyloxy)-3-methylbutanoate
(1r,2r,3s,4s,5r,8r,9r,10r,12z,14s,17r)-10-(acetyloxy)-4,5,9-trihydroxy-4,8,12,17-tetramethyl-16-oxo-15,18-dioxatetracyclo[12.4.0.0¹,¹⁷.0³,⁸]octadeca-6,12-dien-2-yl acetate
6-[(4-hydroxy-3-methoxy-2-methyl-9h-carbazol-1-yl)methyl]-3-methoxy-1,2-dimethyl-9h-carbazol-4-ol
methyl 8-hydroxy-10-(hydroxymethyl)-3-methylidene-4,5-bis[(2-methylpropanoyl)oxy]-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1r,2s,4as,5r,6r,8r,8ar)-2-(acetyloxy)-5-[2-(furan-3-yl)ethyl]-4a,6,8-trihydroxy-5,6-dimethyl-7-oxo-tetrahydrospiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(1r,2s,6r,7r,9s,12s,13s)-12-(acetyloxy)-13-(hydroxymethyl)-9-methyl-5-methylidene-4-oxo-3,14-dioxatricyclo[7.4.1.0²,⁶]tetradecan-7-yl (2z)-2-[(acetyloxy)methyl]but-2-enoate
(1s,3s,4s,7r,8r)-8-(2,4-dihydroxy-3,5-dimethylbenzoyl)-3-hydroxy-5-[(2e,4e)-1-hydroxyhexa-2,4-dien-1-ylidene]-1,3-dimethyl-7-[(1e)-prop-1-en-1-yl]bicyclo[2.2.2]octane-2,6-dione
13-[(acetyloxy)methyl]-12-hydroxy-9-methyl-5-methylidene-4-oxo-3,14-dioxatricyclo[7.4.1.0²,⁶]tetradecan-7-yl 4-(acetyloxy)-2-methylbut-2-enoate
(1r,2s,3s,4r,6s,8s,11z)-3-(acetyloxy)-11-{2-[(1r)-1-(acetyloxy)-3,3-dimethylcyclohexyl]ethylidene}-10-oxo-5,7,9-trioxatricyclo[6.3.0.0²,⁶]undecan-4-yl acetate
(3s)-3,6,7,11-tetrahydroxy-2,2-dimethyl-8,9-bis(3-methylbut-2-en-1-yl)-3,4-dihydro-1,5-dioxatetraphen-10-one
2-(acetyloxy)-5-[2-(furan-3-yl)ethyl]-4a,6,8-trihydroxy-5,6-dimethyl-7-oxo-tetrahydrospiro[naphthalene-1,2'-oxiran]-8a-ylmethyl acetate
(3r)-3,6,8,12-tetrahydroxy-2,2-dimethyl-7,11-bis(3-methylbut-2-en-1-yl)-3,4-dihydro-1,10-dioxatetraphen-5-one
3,3,12,17,26-pentamethyl-4,18-dioxa-12,26-diazaheptacyclo[15.11.1.0²,¹⁵.0⁵,¹⁴.0⁶,¹¹.0¹⁹,²⁸.0²⁰,²⁵]nonacosa-5(14),6,8,10,15,19(28),20,22,24-nonaene-13,27-dione
8β-hydroxy-teucrolivin b
{"Ingredient_id": "HBIN013674","Ingredient_name": "8\u03b2-hydroxy-teucrolivin b","Alias": "NA","Ingredient_formula": "C24H32O10","Ingredient_Smile": "CC(=O)OCC12C(C(=O)C(C(C1(CCC(C23CO3)OC(=O)C)O)(C)CCC4=COC=C4)(C)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10760","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
acevaltrate
{"Ingredient_id": "HBIN014504","Ingredient_name": "acevaltrate","Alias": "NA","Ingredient_formula": "C24H32O10","Ingredient_Smile": "CC(C)CC(=O)OC1C2C(=CC(C23CO3)OC(=O)CC(C)(C)OC(=O)C)C(=CO1)COC(=O)C","Ingredient_weight": "480.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "534","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "137706187","DrugBank_id": "NA"}
ailantinol g
{"Ingredient_id": "HBIN014946","Ingredient_name": "ailantinol g","Alias": "NA","Ingredient_formula": "C24H32O10","Ingredient_Smile": "CCC(C)(C(=O)OC1C2C(C(C3(C4C2(CO3)C(CC4(C)C5C(=CC(=O)O5)C)OC1=O)O)O)C)O","Ingredient_weight": "480.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "780","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "10896127","DrugBank_id": "NA"}